{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T04:11:26Z","timestamp":1775016686133,"version":"3.50.1"},"reference-count":53,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Human Immunology"],"published-print":{"date-parts":[[2022,4]]},"DOI":"10.1016\/j.humimm.2022.01.004","type":"journal-article","created":{"date-parts":[[2022,1,10]],"date-time":"2022-01-10T05:03:10Z","timestamp":1641790990000},"page":"346-355","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"title":["Designing of a bispecific antibody against SARS-CoV-2 spike glycoprotein targeting human entry receptors DPP4 and ACE2"],"prefix":"10.1016","volume":"83","author":[{"given":"Rupal","family":"Ojha","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kiran","family":"Gurjar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tadi Sai","family":"Ratnakar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amit","family":"Mishra","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vijay Kumar","family":"Prajapati","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.humimm.2022.01.004_b0005","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.jare.2020.03.005","article-title":"COVID-19 infection: Origin, transmission, and characteristics of human coronaviruses","volume":"24","author":"Shereen","year":"2020","journal-title":"J. Adv. Res."},{"issue":"10223","key":"10.1016\/j.humimm.2022.01.004_b0010","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1016\/S0140-6736(20)30185-9","article-title":"A novel coronavirus outbreak of global health concern","volume":"395","author":"Wang","year":"2020","journal-title":"Lancet"},{"issue":"3","key":"10.1016\/j.humimm.2022.01.004_b0015","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1038\/s41579-018-0118-9","article-title":"Origin and evolution of pathogenic coronaviruses","volume":"17","author":"Cui","year":"2019","journal-title":"Nat. Rev. Microbiol."},{"key":"10.1016\/j.humimm.2022.01.004_b0020","unstructured":"J. Lee, G. Chowell, E. Jung, A dynamic compartmental model for the Middle East respiratory syndrome outbreak in the Republic of Korea: A retrospective analysis on control interventions and superspreading events, J. Theor. Biol. (2020)."},{"key":"10.1016\/j.humimm.2022.01.004_b0025","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12985-020-01369-z","article-title":"SARS-CoV-2: characteristics and current advances in research","volume":"17","author":"Yang","year":"2020","journal-title":"Virol. J."},{"issue":"7818","key":"10.1016\/j.humimm.2022.01.004_b0030","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1038\/s41586-020-2312-y","article-title":"The pathogenicity of SARS-CoV-2 in hACE2 transgenic mice","volume":"583","author":"Bao","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.humimm.2022.01.004_b0035","article-title":"Structure, function and antigenicity of the SARS-CoV-2 spike glycoprotein","author":"Walls","year":"2020","journal-title":"BioRxiv"},{"issue":"1","key":"10.1016\/j.humimm.2022.01.004_b0040","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.ajpath.2015.09.014","article-title":"Dipeptidyl Peptidase 4 Distribution in the Human Respiratory Tract Implications for the Middle East Respiratory Syndrome","volume":"186","author":"Meyerholz","year":"2016","journal-title":"Am. J. Pathol."},{"issue":"6","key":"10.1016\/j.humimm.2022.01.004_b0045","doi-asserted-by":"crossref","first-page":"101160","DOI":"10.1016\/j.isci.2020.101160","article-title":"The MERS-CoV Receptor DPP4 as a Candidate Binding Target of the SARS-CoV-2 Spike","volume":"23","author":"Li","year":"2020","journal-title":"IScience"},{"key":"10.1016\/j.humimm.2022.01.004_b0050","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1080\/22221751.2020.1739565","article-title":"Emerging WuHan (COVID-19) coronavirus: glycan shield and structure prediction of spike glycoprotein and its interaction with human CD26, Emerg","volume":"9","author":"Vankadari","year":"2020","journal-title":"Microbes Infect."},{"issue":"2020","key":"10.1016\/j.humimm.2022.01.004_b0055","first-page":"727","article-title":"A Novel Coronavirus from Patients with Pneumonia in China","volume":"382","author":"Zhu","year":"2019","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.humimm.2022.01.004_b0060","unstructured":"M. Angel, crossm Compounds with Therapeutic Potential against Novel, (2020) 1\u20137."},{"key":"10.1016\/j.humimm.2022.01.004_b0065","doi-asserted-by":"crossref","unstructured":"J. Xu, S. Zhao, T. Teng, A.E. Abdalla, W. Zhu, Systematic Comparison of Two Animal-to-Human Transmitted Human Coronaviruses\u00a0: SARS-CoV-2 and, (2020). https:\/\/doi.org\/10.3390\/v12020244.","DOI":"10.3390\/v12020244"},{"key":"10.1016\/j.humimm.2022.01.004_b0070","doi-asserted-by":"crossref","unstructured":"R. Fleischmann, M.C. Genovese, Y. Lin, G.S. John, J.A. Maldonado-cocco, M. Stanislav, A.J. Kivitz, Original article Long-term safety of sarilumab in rheumatoid arthritis\u00a0: an integrated analysis with up to 7 years \u2019, (2020) 292\u2013302. https:\/\/doi.org\/10.1093\/rheumatology\/kez265.","DOI":"10.1093\/rheumatology\/kez265"},{"key":"10.1016\/j.humimm.2022.01.004_b0075","first-page":"277","volume":"25","author":"Hu","year":"2012","journal-title":"SARS-CoV Regulates Immune Function-Related"},{"key":"10.1016\/j.humimm.2022.01.004_b0080","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12929-019-0592-z","article-title":"Development of therapeutic antibodies for the treatment of diseases","volume":"27","author":"Lu","year":"2020","journal-title":"J. Biomed. Sci."},{"key":"10.1016\/j.humimm.2022.01.004_b0085","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2020.104866","article-title":"The CoV-2 outbreak: how haemotologists could help to fight Covid-19","author":"Galimberti","year":"2020","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.humimm.2022.01.004_b0090","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/vaccines9030243","article-title":"Emerging sars-cov-2 variants and impact in global vaccination programs against sars-cov-2\/covid-19","volume":"9","author":"G\u00f3mez","year":"2021","journal-title":"Vaccines"},{"issue":"1","key":"10.1016\/j.humimm.2022.01.004_b0095","doi-asserted-by":"crossref","DOI":"10.1007\/s40203-020-00055-w","article-title":"Peptide modelling and screening against human ACE2 and spike glycoprotein RBD of SARS - CoV - 2","volume":"8","author":"Rathod","year":"2020","journal-title":"Silico Pharmacol."},{"key":"10.1016\/j.humimm.2022.01.004_b0100","doi-asserted-by":"crossref","first-page":"W296","DOI":"10.1093\/nar\/gky427","article-title":"SWISS-MODEL: Homology modelling of protein structures and complexes","volume":"46","author":"Waterhouse","year":"2018","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.humimm.2022.01.004_b0105","doi-asserted-by":"crossref","unstructured":"K. Karunakaran, M. Ganapathiraju, Interactome of SARS-CoV-2 \/ nCoV19 modulated host proteins with computationally predicted PPIs, Res. Sq. (2020). https:\/\/doi.org\/10.21203\/rs.3.rs-28592\/v1.","DOI":"10.21203\/rs.3.rs-28592\/v1"},{"key":"10.1016\/j.humimm.2022.01.004_b0110","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/ijms22030992","article-title":"Can SARS-CoV-2 virus use multiple receptors to enter host cells?","volume":"22","author":"Gadanec","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.humimm.2022.01.004_b0115","doi-asserted-by":"crossref","first-page":"D607","DOI":"10.1093\/nar\/gky1131","article-title":"STRING v11: Protein-protein association networks with increased coverage, supporting functional discovery in genome-wide experimental datasets","volume":"47","author":"Szklarczyk","year":"2019","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.humimm.2022.01.004_b0120","doi-asserted-by":"crossref","first-page":"D383","DOI":"10.1093\/nar\/gkz827","article-title":"Thera-SAbDab: The Therapeutic Structural Antibody Database","volume":"48","author":"Raybould","year":"2020","journal-title":"Nucleic Acids Res."},{"issue":"1","key":"10.1016\/j.humimm.2022.01.004_b0125","article-title":"A therapeutic neutralizing antibody targeting receptor binding domain of SARS-CoV-2 spike protein","volume":"12","author":"Kim","year":"2021","journal-title":"Nat. Commun."},{"key":"10.1016\/j.humimm.2022.01.004_b0130","doi-asserted-by":"crossref","first-page":"104866","DOI":"10.1016\/j.phrs.2020.104866","article-title":"The CoV-2 outbreak: how hematologists could help to fight Covid-19","volume":"157","author":"Galimberti","year":"2020","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.humimm.2022.01.004_b0135","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fphar.2020.01161","article-title":"DPP4 and ACE2 in Diabetes and COVID-19: Therapeutic Targets for Cardiovascular Complications?","volume":"11","author":"Valencia","year":"2020","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.humimm.2022.01.004_b0140","first-page":"1","article-title":"Fc engineering for developing therapeutic bispecific antibodies and novel scaffolds","volume":"8","author":"Liu","year":"2017","journal-title":"Front. Immunol."},{"key":"10.1016\/j.humimm.2022.01.004_b0145","doi-asserted-by":"crossref","unstructured":"J.T. Regula, S. Imhof-Jung, M. M\u00f8lh\u00f8j, J. Benz, A. Ehler, A. Bujotzek, W. Schaefer, C. Klein, Variable heavy-variable light domain and Fab-arm CrossMabs with charged residue exchanges to enforce correct light chain assembly, Protein Eng. Des. Sel. 31 (2018) 289\u2013299. https:\/\/doi.org\/10.1093\/protein\/gzy021.","DOI":"10.1093\/protein\/gzy021"},{"issue":"7","key":"10.1016\/j.humimm.2022.01.004_b0150","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1093\/protein\/9.7.617","article-title":"\u201cKnobs-into-holes\u201d engineering of antibody C(H)3 domains for heavy chain heterodimerization","volume":"9","author":"Ridgway","year":"1996","journal-title":"Protein Eng."},{"issue":"5","key":"10.1016\/j.humimm.2022.01.004_b0155","doi-asserted-by":"crossref","first-page":"1829","DOI":"10.1038\/s41596-020-0312-x","article-title":"The HDOCK server for integrated protein\u2013protein docking","volume":"15","author":"Yan","year":"2020","journal-title":"Nat. Protoc."},{"issue":"12","key":"10.1016\/j.humimm.2022.01.004_b0160","doi-asserted-by":"crossref","first-page":"e05739","DOI":"10.1016\/j.heliyon.2020.e05739","article-title":"Identifying epitopes for cluster of differentiation and design of new peptides inhibitors against human SARS-CoV-2 spike RBD by an in-silico approach","volume":"6","author":"Akachar","year":"2020","journal-title":"Heliyon"},{"issue":"D1","key":"10.1016\/j.humimm.2022.01.004_b0165","doi-asserted-by":"crossref","first-page":"D1147","DOI":"10.1093\/nar\/gkt1191","article-title":"AVPdb: A database of experimentally validated anti-viral peptides targeting medically important viruses","volume":"42","author":"Qureshi","year":"2014","journal-title":"Nucleic Acids Res."},{"issue":"Web Server","key":"10.1016\/j.humimm.2022.01.004_b0170","doi-asserted-by":"crossref","first-page":"W202","DOI":"10.1093\/nar\/gkl343","article-title":"AlgPred: Prediction of allergenic proteins and mapping of IgE epitopes","volume":"34","author":"Saha","year":"2006","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.humimm.2022.01.004_b0175","unstructured":"BMC Bioinformatics, antigens and subunit vaccines (2021) 1\u20132."},{"issue":"9","key":"10.1016\/j.humimm.2022.01.004_b0180","doi-asserted-by":"crossref","first-page":"e73957","DOI":"10.1371\/journal.pone.0073957","article-title":"In silico approach for predicting toxicity of peptides and proteins","volume":"8","author":"Gupta","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.humimm.2022.01.004_b0185","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1471-2105-15-282","article-title":"Designing of peptides with desired half-life in intestine-like environment","volume":"15","author":"Sharma","year":"2014","journal-title":"BMC Bioinform."},{"key":"10.1016\/j.humimm.2022.01.004_b0190","doi-asserted-by":"crossref","first-page":"605","DOI":"10.2147\/IJN.S184911","article-title":"Designing and enhancing the antifungal activity of corneal specific cell penetrating peptide using gelatin hydrogel delivery system","volume":"14","author":"Amit","year":"2019","journal-title":"Int. J. Nanomed."},{"issue":"W1","key":"10.1016\/j.humimm.2022.01.004_b0195","doi-asserted-by":"crossref","first-page":"W449","DOI":"10.1093\/nar\/gkw329","article-title":"PEP-FOLD3: faster de novo structure prediction for linear peptides in solution and in complex","volume":"44","author":"Lamiable","year":"2016","journal-title":"Nucleic Acids Res."},{"issue":"3","key":"10.1016\/j.humimm.2022.01.004_b0200","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1021\/acs.bioconjchem.8b00865","article-title":"Site-Specific Chemical Conjugation of Antibodies by Using Affinity Peptide for the Development of Therapeutic Antibody Format","volume":"30","author":"Kishimoto","year":"2019","journal-title":"Bioconjug. Chem."},{"issue":"4","key":"10.1016\/j.humimm.2022.01.004_b0205","doi-asserted-by":"crossref","first-page":"561","DOI":"10.3390\/ijms17040561","article-title":"Linkers having a crucial role in antibody\u2013drug conjugates","volume":"17","author":"Lu","year":"2016","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.humimm.2022.01.004_b0210","doi-asserted-by":"crossref","first-page":"513","DOI":"10.2144\/000113450","article-title":"Design of an in vivo cleavable disulfide linker in recombinant fusion protein","volume":"49","author":"Xiaoying Chen","year":"2010","journal-title":"Biotechniques"},{"issue":"11","key":"10.1016\/j.humimm.2022.01.004_b0215","doi-asserted-by":"crossref","first-page":"e50300","DOI":"10.1371\/journal.pone.0050300","article-title":"PROSPER: An Integrated Feature-Based Tool for Predicting Protease Substrate Cleavage Sites","volume":"7","author":"Song","year":"2012","journal-title":"PLoS One"},{"issue":"12","key":"10.1016\/j.humimm.2022.01.004_b0220","doi-asserted-by":"crossref","first-page":"994","DOI":"10.3390\/ma9120994","article-title":"Fc-binding ligands of immunoglobulin G: An overview of high affinity proteins and peptides","volume":"9","author":"Choe","year":"2016","journal-title":"Materials (Basel)"},{"key":"10.1016\/j.humimm.2022.01.004_b0225","doi-asserted-by":"crossref","unstructured":"U. States, S.E. Galloway, P. Paul, D.R. Maccannell, M.A. Johansson, Emergence of SARS-CoV-2 B . 1 . 1 . 7 Lineage \u2014, 70 (2021) 95\u201399.","DOI":"10.15585\/mmwr.mm7003e2"},{"key":"10.1016\/j.humimm.2022.01.004_b0230","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1002\/prot.26042","article-title":"Human SARS CoV-2 spike protein mutations","volume":"89","author":"Guruprasad","year":"2021","journal-title":"Proteins Struct. Funct. Bioinform."},{"issue":"1","key":"10.1016\/j.humimm.2022.01.004_b0235","doi-asserted-by":"crossref","DOI":"10.1038\/s41421-020-0153-3","article-title":"Network-based drug repurposing for novel coronavirus 2019-nCoV\/SARS-CoV-2","volume":"6","author":"Zhou","year":"2020","journal-title":"Cell Discov."},{"issue":"4","key":"10.1016\/j.humimm.2022.01.004_b0240","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1038\/s41422-020-0305-x","article-title":"Inhibition of SARS-CoV-2 (previously 2019-nCoV) infection by a highly potent pan-coronavirus fusion inhibitor targeting its spike protein that harbors a high capacity to mediate membrane fusion","volume":"30","author":"Xia","year":"2020","journal-title":"Cell Res."},{"key":"10.1016\/j.humimm.2022.01.004_b0245","doi-asserted-by":"crossref","unstructured":"AR and YI. Satoka Mori, Arisa Abe, Naoto Ishikawa, A novel site-specific chemical conjugation of IgG antibodies by affinity peptide for immunoassays, J. Biochem. (2020). https:\/\/doi.org\/10.1093\/jb\/mvaa084.","DOI":"10.1093\/jb\/mvaa084"},{"key":"10.1016\/j.humimm.2022.01.004_b0250","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/0076-6879(86)21019-8","article-title":"Bispecific monoclonal antibodies from hybrid hybridomas","volume":"121","author":"Suresh","year":"1986","journal-title":"Methods Enzymol."},{"key":"10.1016\/j.humimm.2022.01.004_b0255","doi-asserted-by":"crossref","unstructured":"H. Lindhofer, R. Mocikat, B. Steipe, S. Thierfelder, Preferential species-restricted heavy\/light chain pairing in rat\/mouse quadromas. Implications for a single-step purification of bispecific antibodies., J. Immunol. 155 (1995) 219 LP \u2013 225.","DOI":"10.4049\/jimmunol.155.1.219"},{"issue":"6","key":"10.1016\/j.humimm.2022.01.004_b0260","doi-asserted-by":"crossref","first-page":"872","DOI":"10.4161\/mabs.26307","article-title":"Knobs-into-holes antibody production in mammalian cell lines reveals that asymmetric afucosylation is sufficient for full antibody-dependent cellular cytotoxicity","volume":"5","author":"Shatz","year":"2013","journal-title":"MAbs"},{"issue":"16","key":"10.1016\/j.humimm.2022.01.004_b0265","doi-asserted-by":"crossref","first-page":"4476","DOI":"10.1073\/pnas.1525360113","article-title":"Ang-2\/VEGF bispecific antibody reprograms macrophages and resident microglia to anti-tumor phenotype and prolongs glioblastoma survival","volume":"113","author":"Kloepper","year":"2016","journal-title":"Proc. Natl. Acad. Sci. U. S. A."}],"container-title":["Human Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0198885922000064?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0198885922000064?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T11:55:04Z","timestamp":1759319704000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0198885922000064"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,4]]},"references-count":53,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2022,4]]}},"alternative-id":["S0198885922000064"],"URL":"https:\/\/doi.org\/10.1016\/j.humimm.2022.01.004","relation":{},"ISSN":["0198-8859"],"issn-type":[{"value":"0198-8859","type":"print"}],"subject":[],"published":{"date-parts":[[2022,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Designing of a bispecific antibody against SARS-CoV-2 spike glycoprotein targeting human entry receptors DPP4 and ACE2","name":"articletitle","label":"Article Title"},{"value":"Human Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.humimm.2022.01.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 American Society for Histocompatibility and Immunogenetics. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}